Terns Pharmaceuticals, Inc. (NASDAQ:TERN) appears in 242 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 2,642,910 | 47.61% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 356,513 | 4.70% | $0.00 |
| Vivo Capital, LLC | 31 Dec, 2025 | 0 | -1,548,818 | -22.46% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 4,350,000 | 0.00% | $0.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 0 | 1,611,000 | 40.90% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 4,500,000 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -54,107 | -24.02% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 964,031 | 21.14% | $0.00 |
| Holocene Advisors, LP | 31 Dec, 2025 | 0 | 2,775,493 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 485 | 769.84% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 3,379,569 | 0.00% | $0.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Dec, 2025 | 0 | -225,000 | -11.41% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | 1,577,308 | 99.24% | $0.00 |
| Nearwater Capital Markets, Ltd | 31 Dec, 2025 | 0 | 1,704,800 | 0.00% | $0.00 |
| Franklin Resources Inc | 31 Dec, 2025 | 0 | 1,453,849 | 113.81% | $0.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 0 | 1,432,176 | 872.20% | $0.00 |
| LORD, ABBETT & CO. LLC | 31 Dec, 2025 | 0 | 2,712,399 | 0.00% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 472,912 | 42.83% | $0.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 0 | -5,409,671 | -71.53% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | -4,225,000 | -74.12% | $0.00 |